News about "Patent License agreement "

Cipla and Takeda to Commercialize Vonoprazan in India

Cipla and Takeda to Commercialize Vonoprazan in India

Cipla has signed a non-exclusive Patent License agreement with Takeda Pharmaceutical company Ltd. for ‘Vonoprazan’ for India Market for treating acid-related illnesses among patients.

Patent License Agreement | 27/06/2024 | By Aishwarya 326


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members